PECAM1 Mouse

Platelet Endothelial Cell Adhesion Molecule 1 MouseRecombinant
Shipped with Ice Packs
In Stock

Description

Introduction to PECAM1 in Mice

Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1), encoded by the Pecam1 gene in mice, is a 130 kDa transmembrane glycoprotein belonging to the immunoglobulin superfamily . It is expressed on endothelial cells, platelets, monocytes, neutrophils, and subsets of lymphocytes, playing critical roles in vascular biology, immune regulation, and cell signaling . Mouse models of PECAM-1 deficiency (Pecam1<sup>−/−</sup>) have been instrumental in elucidating its functions in inflammation, angiogenesis, and disease progression .

Pecam1 Gene Structure

The Pecam1 gene (Ensembl ID: ENSMUSG00000020717) produces eight splice variants with diverse protein isoforms :

Transcript IDProtein LengthBiotypeUniProt IDKey Features
ENSMUST00000068021.9732 aaProtein codingB1ARB3Canonical, TSL:2
ENSMUST00000106796.9727 aaProtein codingQ08481-1CCDS79069, TSL:1
ENSMUST00000080853.11716 aaProtein codingQ08481-3CCDS25559, TSL:1
ENSMUST00000183610.8626 aaProtein codingQ08481-4CCDS79068, TSL:1

TSL: Transcript Support Level; aa: amino acids .

Protein Domains and Interactions

  • Structure: Comprises six extracellular Ig-like domains, a transmembrane domain, and a cytoplasmic tail with immunoregulatory tyrosine motifs (ITIM/ITSM) .

  • Interactions: Mediates homophilic (cell-cell) and heterophilic (e.g., CD38 on NK cells) binding . Phosphorylated tyrosine residues recruit SHP-2, modulating leukocyte activation and vascular signaling .

Leukocyte Transmigration

PECAM-1 facilitates neutrophil and monocyte migration through endothelial junctions. In Pecam1<sup>−/−</sup> mice:

  • Peritonitis Model: Neutrophils exhibit delayed detachment from vessel walls, impairing migration to inflammatory sites .

  • Experimental Autoimmune Encephalomyelitis (EAE): Earlier onset of symptoms and enhanced leukocyte infiltration into the CNS .

Angiogenesis and Vascular Integrity

  • Atherosclerosis: Pecam1<sup>−/−</sup> Apoe<sup>−/−</sup> mice show reduced lesion formation due to suppressed NF-κB signaling in endothelial cells .

  • Vascular Permeability: Prolonged endothelial barrier disruption in response to histamine .

Tumor Microenvironment Modulation

  • B16-F10 Melanoma: Pecam1<sup>−/−</sup> mice exhibit reduced tumor cell proliferation and altered histology in pre-angiogenic lesions .

  • Mechanism: Loss of PECAM-1 decreases TIMP-1, IL-11, and other pro-metastatic factors in co-culture models .

Autoimmune and Inflammatory Diseases

ModelPhenotype in Pecam1<sup>−/−</sup> MiceMechanismCitation
EAE (Multiple Sclerosis)Early symptom onset, increased CNS vascular leakImpaired leukocyte transmigration
Collagen-Induced ArthritisHigher disease severityLoss of ITIM-mediated anti-inflammatory signaling

Cancer and Metastasis

ObservationWild-Type vs. Pecam1<sup>−/−</sup> MiceCitation
Tumor cell proliferation (PCNA staining)58% vs. 32% in pre-angiogenic nodules
Endothelial-derived TIMP-1 levels120 pg/mL vs. 45 pg/mL

Research Tools and Antibodies

  • MEC7.46 Antibody: Targets endothelial-specific PECAM-1 isoform (130 kDa), used for immunohistochemistry and flow cytometry .

  • Recombinant Mouse PECAM-1: Utilized in adhesion assays (R&D Systems #3628-PC-050) .

Therapeutic Implications

  • Neutrophil Detachment: CD31 agonist peptides restore migration defects in Pecam1<sup>−/−</sup> mice .

  • Vascular-Targeted Therapies: Modulating PECAM-1 signaling may improve outcomes in chronic inflammation or cancer .

Product Specs

Introduction
Platelet endothelial cell adhesion molecule (PECAM1) plays a crucial role in atherosclerosis development. It protects healthy cells from being engulfed by phagocytes by sending detachment signals. However, in apoptotic cells, PECAM1 changes its function and promotes the binding of dying cells to phagocytes. When a viable cell interacts with a phagocyte through the homophilic binding of PECAM1 on both cell surfaces, it triggers the active repulsion of the viable cell from the phagocyte.
Description
Recombinant Mouse PECAM1, expressed in HEK293 cells, is a single, non-glycosylated polypeptide chain. It consists of 579 amino acids (residues 18-590) and has a molecular weight of 65.3 kDa. The protein is fused to a C-terminal 6-amino acid His-tag and purified using proprietary chromatographic techniques.
Physical Appearance
A clear, colorless solution that has been sterilized by filtration.
Formulation
The provided solution contains 0.25 mg/ml of Mouse PECAM1 protein in a buffer consisting of Phosphate Buffered Saline (pH 7.4) and 10% glycerol.
Stability
For short-term storage (2-4 weeks), the product can be stored at 4°C. For extended storage, freeze the product at -20°C. Adding a carrier protein like 0.1% HSA or BSA is recommended for long-term storage. Repeated freezing and thawing should be avoided.
Purity
The purity of this product is greater than 90%, as determined by SDS-PAGE analysis.
Synonyms
Platelet endothelial cell adhesion molecule, PECAM1, CD31, CD31/EndoCAM, endoCAM, GPIIA', PECA1, PECAM-1, Platelet Endothelial Cell Adhesion Molecule 1.
Source
Sf9, Baculovirus cells.
Amino Acid Sequence

EENSFTINSI HMESLPSWEV MNGQQLTLEC LVDISTTSKS RSQHRVLFYK DDAMVYNVTS REHTESYVIP QARVFHSGKY KCTVMLNNKE KTTIEYEVKV HGVSKPKVTL DKKEVTEGGV VTVNCSLQEE KPPIFFKIEK LEVGTKFVKR RIDKTSNENF VLMEFPIEAQ DHVLVFRCQA GILSGFKLQE SEPIRSEYVT VQESFSTPKF EIKPPGMIIE GDQLHIRCIV QVTHLVQEFT EIIIQKDKAI VATSKQSSEA VYSVMAMVEY SGHYTCKVES NRISKASSIM VNITELFPKP KLEFSSSRLD QGELLDLSCS VSGTPVANFT IQKEETVLSQ YQNFSKIAEE SDSGEYSCTA GIGKVVKRSG LVPIQVCEML SKPSIFHDAK SEIIKGHAIG ISCQSENGTA PITYHLMKAK SDFQTLEVTS NDPATFTDKP TRDMEYQCRA DNCHSHPAVF SEILRVRVIA PVDEVVISIL SSNEVQSGSE MVLRCSVKEG TSPITFQFYK EKEDRPFHQA VVNDTQAFWH NKQASKKQEG QYYCTASNRA SSMRTSPRSS TLAVRVFLAP WKK HHHHH

Q&A

What is the structure and expression pattern of PECAM1 in mice?

PECAM1 in mice is a transmembrane glycoprotein with extracellular, transmembrane, and cytoplasmic domains. The mouse PECAM1 protein spans from Glu18 to Lys590, with homology to human PECAM1 . It is predominantly expressed on:

  • Vascular endothelial cells (particularly concentrated at intercellular junctions)

  • Platelets

  • Subsets of leukocytes, including neutrophils, monocytes, and NK cells

  • Some lymphocyte subpopulations

Expression levels vary by tissue type, with highest expression in highly vascularized tissues. The protein functions as a cell adhesion molecule and participates in cellular signaling pathways critical for vascular integrity and immune cell migration .

How are PECAM1 knockout mice generated and validated?

PECAM1 knockout mice are generated through several approaches:

Global Knockout Method:

  • Target the PECAM1 gene (particularly exons 1 and 2) through homologous recombination in embryonic stem cells

  • Select positive ES cell clones using neomycin resistance

  • Inject targeted ES cells into C57BL/6 blastocysts

  • Implant blastocysts into pseudo-pregnant females

  • Breed chimeric offspring to establish germline transmission

  • Confirm knockout through PCR genotyping, Western blotting, and immunohistochemistry

Conditional Knockout Method:

  • Generate a targeting construct containing loxP sites flanking PECAM1 exons 1 and 2

  • Include a neomycin resistance gene flanked by FRT sites

  • Electroporate into C57BL/6 embryonic stem cells

  • Select and validate correctly targeted ES cell clones

  • Generate chimeric animals by blastocyst injection

  • Breed with FLP1-expressing mice to remove the neomycin cassette

  • Cross PECAM1^flox/flox mice with tissue-specific Cre recombinase-expressing mice

Validation typically involves confirming loss of PECAM1 expression through immunostaining, flow cytometry, and Western blot analysis .

What phenotypic characteristics are observed in PECAM1 knockout mice?

PECAM1 knockout mice exhibit several notable phenotypic characteristics:

Phenotypic FeatureObservation in PECAM1 KO MiceReference
ViabilityViable and fertile with no gross developmental abnormalities
Vascular permeabilityEnhanced and prolonged vascular permeability in response to inflammatory stimuli
Inflammatory responseEarlier onset of clinical symptoms in experimental autoimmune encephalomyelitis (EAE)
Leukocyte transmigrationTransient delay in polymorphonuclear leukocyte trafficking across the subendothelial basal lamina
Recovery from vascular injuryImpaired ability to restore vascular integrity after endothelial disruption
Immune cell migrationEnhanced T lymphocyte transendothelial migration across PECAM-KO endothelial cells

These mice develop normally but show significant alterations in inflammatory responses and vascular integrity maintenance, indicating PECAM1's critical role in these processes .

How does PECAM1 deficiency affect vascular permeability in mouse models?

PECAM1 deficiency significantly impacts vascular permeability regulation:

Mechanistic Basis:

  • PECAM1-deficient endothelial cells exhibit prolonged permeability changes in response to histamine treatment compared to PECAM1-reconstituted cells

  • PECAM1 knockout mice demonstrate exaggerated and prolonged CNS vascular permeability during the development of EAE

  • There is a delay in restoration of dermal vascular integrity following histamine challenge in PECAM1 knockout mice

Molecular Mechanisms:

  • PECAM1 stabilizes endothelial junctions through homophilic binding

  • It participates in signaling pathways that restore barrier function after inflammatory challenges

  • The protein interacts with cytoskeletal components to maintain junction integrity

  • PECAM1 modulates VE-cadherin-based adherens junction stability

Experimental Approach for Studying Permeability:

  • Evans blue extravasation assay to quantify vascular leak

  • Intravital microscopy to visualize real-time permeability changes

  • Transwell permeability assays with isolated endothelial cells

  • Measurement of transendothelial electrical resistance (TEER)

The impaired barrier restoration in PECAM1-deficient models underscores its role as a negative regulator of vascular permeability and importance in maintaining vascular homeostasis .

What is the role of PECAM1 in experimental autoimmune encephalomyelitis (EAE) mouse models?

PECAM1 plays a crucial regulatory role in EAE progression:

Key Findings:

  • PECAM1-deficient mice exhibit an earlier onset of clinical symptoms during EAE compared to wild-type counterparts

  • During EAE, mononuclear cell extravasation and CNS infiltration occur at earlier time points in PECAM1-KO mice

  • The absence of PECAM1 leads to enhanced T lymphocyte transendothelial migration in vitro

Mechanistic Contributions:

  • PECAM1 regulates the integrity of the blood-brain barrier (BBB) during inflammatory challenges

  • It modulates the kinetics and extent of immune cell infiltration into the CNS

  • PECAM1 influences the restoration of vascular integrity after inflammatory insult

Experimental Approaches:

  • MOG immunization model for chronic EAE induction in C57BL/6 mice

  • Clinical scoring to assess disease progression

  • Histopathological examination of CNS tissues for immune cell infiltration

  • In vitro transendothelial migration assays with T cells across PECAM1-deficient endothelial monolayers

  • Assessment of BBB permeability using tracer molecules

The EAE model in PECAM1-deficient mice reveals its importance in regulating both immune cell trafficking and vascular integrity in the context of neuroinflammation .

How does PECAM1 interact with PIEZO1 at cellular junctions in mouse models?

Recent research has uncovered a significant interaction between PECAM1 and PIEZO1:

Interaction Characteristics:

  • PIEZO1 and PECAM1 physically interact at cell-cell junctions, as demonstrated by FRET analysis

  • This interaction is mediated by specific C-terminal residues in PECAM1, particularly Y713

  • The Y713F mutation in PECAM1 prevents FRET signaling with PIEZO1 and reduces PIEZO1 recruitment to junctions

Functional Consequences:

  • PECAM1 inhibits PIEZO1 mechanical sensitivity, shifting the pressure-response curve to the right

  • PECAM1 reduces PIEZO1 activity measured as total charge flow per pressure step

  • This interaction potentially serves as a mechanical sensitivity regulator in endothelial junctions

Experimental Approaches:

  • Patch-clamp recordings of PIEZO1 channel activity in the presence/absence of PECAM1

  • FRET analysis using fluorescently tagged PIEZO1 and PECAM1

  • Site-directed mutagenesis of key residues (Y713F, C622A, S700F)

  • Pressure-response curve analysis to quantify mechanical sensitivity

  • Localization studies with tagged proteins to identify junctional enrichment

This interaction represents a novel mechanism by which PECAM1 regulates mechanosensitivity at vascular junctions, with implications for endothelial responses to flow and pressure .

What are the approaches for creating and utilizing conditional PECAM1 knockout mice?

Conditional PECAM1 knockout mice provide sophisticated tools for tissue-specific analysis:

Generation Strategy:

  • Creation of a targeting construct with loxP sites flanking PECAM1 exons 1 and 2

  • Incorporation of a neomycin resistance gene flanked by FRT sites positioned upstream of the 3' loxP site

  • Electroporation into C57BL/6 embryonic stem cells

  • Injection of correctly targeted ES cells into blastocysts

  • Breeding chimeric animals with FLP1-expressing mice to remove the neomycin cassette

  • Generation of homozygous PECAM1^flox/flox mice

Conditional Knockout Applications:

  • Crossing with Sox2Cre mice to generate global knockouts

  • Crossing with Tie2Cre for endothelial/hematopoietic-specific deletion

  • Crossing with CD11cCre for dendritic cell-specific deletion

  • Crossing with LysMCre for myeloid cell-specific deletion

Validation and Characterization:

  • PCR genotyping to confirm presence of floxed alleles and Cre recombinase

  • Western blot analysis to verify tissue-specific PECAM1 deletion

  • Immunofluorescence to visualize cellular-specific deletion patterns

  • Functional assays to assess tissue-specific consequences

This approach enables researchers to distinguish the roles of PECAM1 in different cell types and overcome the limitations of global knockout models where compensatory mechanisms may mask phenotypes .

How does PECAM1 influence leukocyte transmigration in different inflammatory scenarios?

PECAM1's role in leukocyte transmigration is highly context-dependent:

Leukocyte Subtype Specificity:

  • PECAM1 mediates transmigration of monocytes, neutrophils, and NK cells

  • Only specific subsets of lymphocytes utilize PECAM1 for transmigration

Stimulus Specificity:

Inflammatory StimulusPECAM1 DependencyTissue/Model
IL-1βRequiredMouse cremaster muscle, lung, rat mesentery
TNFαNot requiredMouse cremaster muscle, lung
HCl, adenovirusNot requiredMouse lung
L-NAME, H₂O₂RequiredRat mesentery
FMLP, thrombinNot requiredRat mesentery
IL-8, LTB₄Not requiredIn vitro endothelial models

Mechanistic Contributions:

  • PECAM1 facilitates migration through the endothelial junction via homophilic interactions

  • It mediates migration through the basement membrane via PECAM1-integrin interactions

  • Involvement in intracellular signaling that regulates directional migration

Experimental Approaches:

  • Intravital microscopy to visualize leukocyte-endothelial interactions

  • Transwell migration assays with different inflammatory stimuli

  • Parallel plate flow chamber assays to assess transmigration under flow

  • Tissue-specific analysis of leukocyte infiltration in inflammatory models

This differential involvement highlights PECAM1 as a context-specific regulator of leukocyte transmigration, dependent on both the leukocyte subtype and the nature of the inflammatory stimulus .

What approaches can be used to study recombinant mouse PECAM1 protein in experimental systems?

Recombinant mouse PECAM1 proteins provide valuable tools for mechanistic studies:

Available Forms:

  • Full-length extracellular domain (Glu18-Lys590)

  • Domain-specific constructs

  • Tagged versions (e.g., with C-terminal 6-His tag)

Experimental Applications:

  • Binding Studies:

    • Solid-phase binding assays to identify interaction partners

    • Surface plasmon resonance to determine binding kinetics

    • Co-immunoprecipitation experiments with potential binding partners

  • Functional Assays:

    • Blocking antibody studies to inhibit specific interactions

    • Competition assays with soluble PECAM1 versus membrane-bound forms

    • Reconstitution experiments in PECAM1-deficient systems

  • Structural Studies:

    • Crystallography of PECAM1 domains

    • Cryo-EM for larger complexes

    • Domain mapping for interaction surfaces

  • In vivo Administration:

    • Competitive inhibition of PECAM1-dependent processes

    • Tracking studies with labeled recombinant protein

    • Rescue experiments in PECAM1-deficient animals

Quality Control Parameters:

  • Protein activity measured by binding assays (ED₅₀ of 0.060-0.720 μg/mL)

  • Purity assessment by SDS-PAGE

  • Endotoxin testing for in vivo applications

Recombinant PECAM1 proteins serve as essential tools for dissecting molecular mechanisms in both cell culture and in vivo mouse models .

Product Science Overview

Introduction

Platelet Endothelial Cell Adhesion Molecule 1 (PECAM-1), also known as CD31, is a protein encoded by the PECAM1 gene. It is a member of the immunoglobulin superfamily and is primarily found on the surface of platelets, monocytes, neutrophils, and certain types of T-cells. PECAM-1 plays a crucial role in various physiological processes, including leukocyte migration, angiogenesis, and integrin activation .

Structure and Expression

PECAM-1 is a 130-kilodalton glycoprotein that consists of six extracellular immunoglobulin-like domains, a transmembrane domain, and a cytoplasmic tail containing immunoreceptor tyrosine-based inhibitory motifs (ITIMs). These ITIMs are essential for recruiting and activating protein-tyrosine phosphatases, such as SHP-1 and SHP-2 .

In mice, PECAM-1 is expressed at the lateral junctions of endothelial cells and on the surface of various hematopoietic cells, including monocytes, neutrophils, natural killer cells, platelets, and naive T and B cells . The expression of PECAM-1 is crucial for maintaining the integrity of endothelial cell junctions and facilitating cell-cell adhesion .

Functions

PECAM-1 is involved in several key biological functions:

  1. Leukocyte Transendothelial Migration (TEM): PECAM-1 is required for the efficient migration of leukocytes across endothelial barriers during inflammatory responses. It facilitates the trafficking of leukocytes to and from the lateral border recycling compartment (LBRC), which is essential for TEM .

  2. Angiogenesis: PECAM-1 plays a role in the formation of new blood vessels by promoting endothelial cell-cell adhesion and signaling .

  3. Integrin Activation: PECAM-1 is involved in the activation of integrins, which are essential for cell adhesion and signaling .

  4. Regulation of B-cell Development: PECAM-1 acts as a regulator of B-cell development and activation. PECAM-1-deficient mice exhibit a hyperresponsive B-cell phenotype, increased numbers of B-1 cells, and reduced B-2 cells. These mice also develop autoantibodies and lupus-like autoimmune disease with age .

  5. Negative Regulation of Platelet-Collagen Interactions: PECAM-1 negatively regulates platelet-collagen interactions, which are crucial for platelet adhesion and aggregation during blood clotting .

Recombinant PECAM-1 in Research

Recombinant PECAM-1, particularly from mouse sources, is widely used in research to study its functions and interactions. Recombinant proteins are produced using various expression systems, such as bacterial, yeast, insect, or mammalian cells. These proteins are then purified and used in various assays to investigate the role of PECAM-1 in different biological processes.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.